Skip to content
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals

Discovering better medicines through target-centric TPD powered by MOPED™ Glue Platform

We are a U.S.-based biotech company focused on discovering and developing transformative therapies.

Our proprietary MOPED™ molecular glue platform complements SK Life Science Labs’ core targeted protein degradation (TPD) platform. By leveraging our cutting-edge platforms and harnessing our deep drug-hunting expertise, we are determined to build a future where we’ll change the outcome of currently life-altering diseases.

Our Purpose

We are dedicated to the discovery and development of degrader medicines that will treat debilitating diseases to improve the lives of patients.
Learn More

Ethics & Compliance Program

Learn about our commitment to ethical management.
Learn More

News & Media

Learn more about recent news.
Learn More

Built for the Future

Empowered by our TPD discovery engine, preclinical, and investigational new drug (IND) enabling capabilities, we have established a robust foundation. Joining SK Biopharmaceuticals gives us access to clinical capabilities, positioning us for unparalleled success in the future.
Learn More